US Patent No. 11,154,522; Dermala has been awarded a patent for acne preparations and treatments, the second in the company’s intellectual property portfolio that includes the use of the human microbiome to treat acne. Treat and prevent acne. The company has developed a new technology to enhance targeted delivery of post-biotic metabolites derived from human microorganisms into specific layers of the skin. This results in a higher therapeutic effect due to the targeted inhibition of C. acnes in the follicle and reduces inflammation while avoiding side effects. Microbiome-derived postbiotics are derived from beneficial bacteria that help correct acne-related microbiome disturbances and produce faster and longer-lasting results.

Dermala was also awarded another patent earlier this year for acne care postbiotics.

This week, the company was recognized in Cosmopolitan’s first ever Acne Holy Grail Award. The company chose Dermala’s Oat So Sweet Daily Moisturizer for Blemish-Pone Skin as its best moisturizer.

Oat So Sweet is a mild moisturizer formulated with prebiotics and postbiotics to balance and restore the skin’s microbiome. Key ingredients include colloidal oatmeal, niacinamide, licorice root extract, ceramides, avocado oil, and green tea leaves. Dermala says their patented SE Microbiome and Sugar SE Complex are the real difference in formulas, providing natural prebiotics and postbiotics that support a balanced microbiome by killing C acnes, acne-causing bacteria, and promotes the growth of S. epidermidis, beneficial bacteria that treat acne.

LEAVE A REPLY

Please enter your comment!
Please enter your name here